CorrectSequence Therapeutics
Correct the Gene, Brighten the Future
10 employees · est. 2020 · Shanghai, China
Poseida Therapeutics, Inc.
A Member of the Roche Group
81 employees · est. 2014 · San Diego, United States
Poseida Therapeutics, Inc. is the older company (2020 vs 2014); Poseida Therapeutics, Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | CorrectSequence Therapeutics | Poseida Therapeutics, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2020 | 2014 older |
| Headquarters | ||
| Headquarters | Shanghai, China | San Diego, United States |
| Employees | ||
| Employees | 10 | 81 larger |
| Industry | ||
| Industry | Biotechnology | Biopharma, Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series A | Acquired |
| Total Funding | ||
| Total Funding | $440.00M | $1.88B |
| Funding Rounds | ||
| Funding Rounds | 5 | 9 |
| Services | ||
| Services | Base Editing Technology Innovation, Gene and Cell Therapy, Clinical Trials for Genetic Disorders | Cell Therapy Development, Molecule Development, Patient Support Services, Clinical Trials Management, Scientific Research and Publications |
| Target Customers | ||
| Target Customers | Patients with Severe Genetic Disorders, Healthcare Providers, Pharmaceutical Companies, Research Institutions | Patients, Medical Professionals, Pharmaceutical Partners, Scientists, Healthcare Media |
| Taxonomy | ||
| Taxonomy | Gene Editing Therapies, Transformer Base Editor (tBE), β-hemoglobinopathies, Sickle Cell Disease, Chylomicronemia, Hypertriglyceridemia, Lipid Nanoparticle (LNP) Delivery, Multiplex Editing, Hematopoietic Stem Cells, T Cell Therapy, Adeno-associated Viruses (AAVs), Metabolic Disorders, Cardiovascular Diseases, Oncology | Allogeneic Cell Therapies, Genetic Medicines, Genome Engineering, CAR-T Products, Gene Editing, Non-viral DNA Delivery, Site-Specific Gene Editing System, Chimeric Antigen Receptor, Immunotherapy, Regenerative Medicine, Hematological Malignancies, Solid Tumors, Proprietary Genetic Platforms, In-house GMP Manufacturing, Oncology |
| Website | ||
| Website | correctsequence.com | poseida.com |
About CorrectSequence Therapeutics
CorrectSequence Therapeutics (Correctseq) is a clinical-stage biotech company innovating in the field of gene editing with its proprietary transformer Base Editor (tBE) technology, based in China since its founding in 2020. The company's slogan, "Correct the Gene, Brighten the Future," reflects its...
About Poseida Therapeutics, Inc.
Poseida Therapeutics, Inc., now a Member of the Roche Group, is a clinical-stage biopharmaceutical company based in the United States. Initially founded in 2014, Poseida was acquired by Roche in early 2025, reinforcing its position in the biopharma and biotechnology industries. Pioneering in alloge...
We will tell you when either one moves
BounceWatch watches CorrectSequence Therapeutics and Poseida Therapeutics, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at CorrectSequence Therap... and Poseida Therapeutics,... — by email.
Frequently Asked Questions
Compare CorrectSequence Therapeutics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at CorrectSequence Therapeutics on 15 Jun 2026, and Poseida Therapeutics, Inc. on 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.